Skip to main content
. 2012 Oct 18;3(1):4–11. doi: 10.1016/j.jceh.2012.10.004

Figure 1.

Figure 1

Survival curves comparing participants with elevated serum gamma-glutamyltranspeptidase (GGT) versus normal GGT at baseline who were followed for upto 21-years in the Rancho Bernardo Study for all-cause (a), cardiovascular (b) and liver (c) mortality.